Cascade Technologies Palo Alto

Transcripta Bio, Inc., based in Palo Alto, California, is at the forefront of transcriptome-driven drug discovery, utilizing artificial intelligence to generate comprehensive transcriptomic data that reveals how various drugs influence gene activity. Their platform enables the mapping of chemical structures to gene expression across a vast number of genes, facilitating improved treatment decision-making. The company has developed a high-resolution transcriptomic perturbation atlas that integrates small molecules and diverse cell atlases to identify therapeutic opportunities for a wide range of human diseases. By rapidly synthesizing and validating novel compounds in their lab, Transcripta Bio transforms insights into innovative therapies, positioning themselves as a leader in maximizing therapeutic hypotheses through advanced analytics. Generated from the website

Established in 1999, Accellion is a provider of on-demand secure file transfer appliance and data management solutions with a customer base covering a variety of industries, such as advertising/media production, manufacturing, health care, consumer goods and higher education. The Accellion Courier secure file transfer appliance is file transfer solution. Unlike conventional solutions that can no longer meet security and business requirements, Accellion Courier allows enterprises to eliminate FTP servers, create Sarbanes Oxley compliant business processes, improve e-mail infrastructure performance and reduce information technology management footprint requirements. The company has invested in the development of the core SmartEdge Operating System technology, which enables the company to move, replicate and manage large files. It is a distributed file storage and transmission infrastructure for enterprise applications that unifies and manages multiple storage types. Accellion is a privately held company headquartered in Palo Alto, Calif., with offices in North America, Asia and Europe.